GlassScriptPhysician profile
Alicia Lynn
NPI 1497978514
$803.43
in general payments reported to CMS, 2019-2025
18 companies · $87.26 in 2025
The $87.26 reported for 2025 was more than what a typical Pediatric Emergency Medicine (Pediatrics) provider received nationally (typical 2025 total: $53.43).
See the full distribution for Pediatric Emergency Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $47.80 · 2021: $26.54 · 2023: $136 · 2024: $231 · 2025: $87.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $160.88 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $123.03 | 2024-2025 | |
| Tris Pharma INC | $80.12 | 2019-2020 | |
| Verrica Pharmaceuticals INC. | $67.49 | 2024 | Ycanth |
| Ironshore Pharmaceuticals INC. | $63.90 | 2019-2024 | |
| Sobi, INC | $42.63 | 2019-2023 | |
| Neos Therapeutics, LP | $41.88 | 2019 | |
| Kaleo, INC. | $40.78 | 2019-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $27.81 | 2019-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Genentech USA, INC. | $24.13 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.56 | 2023 | Qelbree |
| Shire North American Group INC | $18.87 | 2019 | |
| Alk-Abello, INC | $18.60 | 2025 | Neffy |
| Pfizer INC. | $16.77 | 2023 | |
| Vertical Pharmaceuticals, LLC | $14.53 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.37 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.76 | 2019 | |
| Adlon Therapeutics L.P. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Lynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.